Clinical Nurse Specialist in Edison, NJ Accepting Medicare
4 Clinical Nurse Specialist nurses found. Showing 1 - 4
 Mr. Jimmy Bernardin, APN Clinical Nurse Specialist - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 65 James St, Edison, NJ 08820 Phone: 732-321-7000 Fax: 732-906-4929 |
 Jiao Li, APN Clinical Nurse Specialist - Adult Health Medicare: Medicare Enrolled Practice Location: 8606 Hana Rd, Edison, NJ 08817 Phone: 201-280-7915 |
Ronald Cha, RN, ACNP-BC Clinical Nurse Specialist - Acute Care Medicare: Medicare Enrolled Practice Location: 34-36 Progress St, Suite A-7, Edison, NJ 08820 Phone: 908-769-1440 Fax: 908-769-0945 |
Mrs. Dolores Prontnicki, PMHCNS-BC Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 65 James St, Edison, NJ 08820 Phone: 732-321-7189 Fax: 732-906-4929 |
News Archive
Study examines bullying, recent alcohol use and heavy drinking episodes among school students
A new study out of the University of Cincinnati finds that both school bullies and their victims are likely to abuse alcohol after a bullying episode. Keith King, a University of Cincinnati professor of health promotion, along with Rebecca Vidourek, a UC assistant professor of health promotion, will present early findings of a new study on Oct. 29, at the 140th Annual Meeting of the American Public Health Association in San Francisco.
Boar's Head promotes healthy lifestyle options and helps champion the cause of diabetes prevention
Boar's Head, a leader in developing fine deli products that respond to consumers' health and wellness concerns, announces an initiative to reach the growing number of Americans now following a gluten free way of life. "Gluten Free with Boar's Head," is reaching out to gluten free followers with news that Boar's Head meats, cheeses and condiments are, and always have been, gluten free.
QLT announces results from Phase II clinical trials and device study for PPDS
QLT Inc. today announced results from Phase II clinical trials and a device study for the punctal plug delivery system (PPDS). These studies are part of a development program that is being conducted by QLT's wholly-owned subsidiary, QLT Plug Delivery, Inc. QLT also announced its plans to expand the program to evaluate a second drug for a new target indication.
pSivida announces presentations on bioerodible technologies for degenerative eye disease
pSivida Corp., a leader in the development of back of the eye drug delivery systems, today announced that two poster presentations will be made at the upcoming ARVO meeting on one of pSivida's next generation bioerodible technologies for degenerative eye disease. It marks a key step toward the ability to use pSivida's bioerodible technologies to develop treatments for glaucoma and other degenerative eye diseases, diseases that affect millions of Americans.
Study illuminates potential way for sticking to weight loss goals
When it comes to losing weight, it's not necessarily slow, but steady, that wins the race, according to new research from Drexel University.
› Verified 7 days ago